Evaluation of most adequate pain medication in uterine artery embolisation for fibroma: PCA versus Epidural Analgesia.

PCA and ketamin versus Epidural Analgesia in pain management of uterine artery embolization in symptomatic uterine leiomyomata.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29678

Enrollment

100

Registered

2008-11-18

Start date

2009-04-06

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

symptomatic uterine leiomyomata embolization post procedural pain epidural analgesia patient controlled analgesia

Interventions

Uterine artery embolization group 1: PCA (morphin + ketamin) group 2: epidural analgesia (bupivacain/naropin) both groups: PCM, diclofenac, tramadol

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women 2. >18 years 3. Premenopausal 4. Symptomatic uterine leiomyoma confirmed by ultrasonography 5. Scheduled (and suitable) for uterine artery embolisation

Exclusion criteria

Exclusion criteria: 1. Wish for future pregnancy 2. Allergy to contrast material 3. Suspection of uterine malignancy

Design outcomes

Primary

Measure	Time frame
- painrelief (NRS)	—

Secondary

Measure	Time frame
- factors predicting amount of pain: amount of embolization material used reduction of volume of uterine leiomyoma others: - hospital stay - costs - adverse effects of analgesia - patient overall satisfaction - number of readmissions because of pain	—

Contacts

Public ContactNanda Meents

barrybalkje@hotmail.com+31 (0)6 24849718

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)